Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank88
3Y CAGR+63.7%
5Y CAGR+20.3%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+63.7%/yr
vs +97.0%/yr prior
5Y CAGR
+20.3%/yr
Recent acceleration
Acceleration
-33.3pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$15.60M-7.7%
2024$16.89M+280.5%
2022$4.44M+24.9%
2021$3.56M-5.6%
2020$3.77M-39.3%
2019$6.20M+153.3%
2018$2.45M+937.3%
2017$236000.00+244.8%
2016$-163000.00-